1999
DOI: 10.1074/jbc.274.12.7619
|View full text |Cite
|
Sign up to set email alerts
|

Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

19
395
1
14

Year Published

1999
1999
2013
2013

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 497 publications
(429 citation statements)
references
References 41 publications
(42 reference statements)
19
395
1
14
Order By: Relevance
“…The impaired binding to rat brain vesicles (Jensen et al, 1998) and in yeast cells suggest that it could lead to a reduction in ␣-syn transport to presynaptic terminals and a loss of function in the asymmetric neuron. On the other hand, A53T ␣-syn was shown to enhance fibrillization in both test tube studies and in transgenic mouse models of synucleionopathies when compared with WT ␣-syn (Conway et al, 1998, Giasson et al, 1999. Thus, the lack of increased vesicle clustering in yeast cells expressing the A53T mutant suggests that this mutation does not cause disease by increasing vesicular accumulation.…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…The impaired binding to rat brain vesicles (Jensen et al, 1998) and in yeast cells suggest that it could lead to a reduction in ␣-syn transport to presynaptic terminals and a loss of function in the asymmetric neuron. On the other hand, A53T ␣-syn was shown to enhance fibrillization in both test tube studies and in transgenic mouse models of synucleionopathies when compared with WT ␣-syn (Conway et al, 1998, Giasson et al, 1999. Thus, the lack of increased vesicle clustering in yeast cells expressing the A53T mutant suggests that this mutation does not cause disease by increasing vesicular accumulation.…”
Section: Discussionmentioning
confidence: 92%
“…␣-syn fibrils exhibit properties of amyloid (Spillantini et al, 1998), and ␣-syn assembles into amyloid fibrils in vitro (Han et al, 1995;Giasson et al, 1999), whereas SNCA mutations can accelerate ␣-syn fibrillization (Conway et al, 1998;Greenbaum et al, 2005). Therefore, it is plausible that ␣-syn misfolds and aggregates into amyloid fibrils that are neurotoxic and play a causative role in the pathogenesis of PD.…”
Section: Introductionmentioning
confidence: 99%
“…The N-terminal region and β-sheet formation in this region was also proposed to be crucial in fibril formation, yet we detect a decrease in β-sheet formation in the N-terminal region, which indicates rather an inhibition of fibril formation via the N-terminal region. 17,29,42,43 Abundant (up to 55%) turn structure formation occurs in the C-terminal region of the wild-and A30P mutant-type αS proteins. Large decreases in the tendencies toward turn structure formation occur in the N-terminal region at Glu28-Pro30 and in the Cterminal region (Gln109-Asp115) with a difference up to 30%.…”
mentioning
confidence: 99%
“…[15][16][17][18] Diverse oligomeric forms of the protein have also been observed, including short, ring-like protofibrils, short chain protofibrils, 19 and other more globular forms with different secondary structure contents. 20 Because some of the PD linked aS mutations accelerate fibril formation (A53T, E46K) [21][22][23][24][25] while others inhibit it (A30P), 19 but all increase oligomer formation, oligomers have been proposed to be the toxic forms of the protein. 19,21,26,27 The formation of amyloid fibrils by aS occurs via a nucleation dependent pathway, 28 with access to the pathway controlled by conformational intermediates.…”
Section: Introductionmentioning
confidence: 99%